About AllerGen
Network Governance - Board of Directors
AllerGen NCE Inc. is governed by an independent Board of Directors. Board Directors are committed to the vision and mission of AllerGen, promoting an atmosphere where excellent research combines with industrial know-how to produce socio-economic benefits for Canadians.
Chair: Mr. Graham W.S. Scott, C.M., Q.C., CEO, Graham Scott Strategies Inc.
Scientific Director and CEO: Dr. Judah A. Denburg, AllerGen NCE Inc., McMaster University
Dr. Douglas Barber, Distinguished Professor-in-Residence, McMaster University
Dr. Howard Bergman, Dr. Joseph Kaufman Chair in Geriatrics; Professor of Medicine, McGill University
Dr. Mark Bisby, Consultant
Dr. Zave Chad, Allergist and Clinical Immunologist (Associate Professor, University of Ottawa)
Dr. Deborah Danoff MD, FRCP(C), University of Ottawa
Dr. Patrick Deane, President and Vice-Chancellor, McMaster University
Dr. Christine Hampson, President and CEO, The Sandbox Project
Dr. John Gordon, Professor, Department of Medicine, University of Saskatchewan; Director, Canadian Centre for Health & Safety in Agriculture
Dr. Eric Leith, MD, FRCP(C), Allergist and Immunologist, Chair, Canadian Allergy, Asthma and Immunology Foundation
Mr. Paul Lucas, President and CEO, GlaxoSmithKline Canada
Dr. Janice MacKinnon, Professor, School of Public Health, University of Saskatchewan
Dr. Claude Roy, Vice-Chair, BOD, Gastroenterologist and Professor Emeritus, Hôpital Ste-Justine
Dr. Elinor Wilson, President and CEO, Assisted Human Reproduction Canada
Ex Officio
Lisa Drouillard, Program Deputy Director, NCE/CECR Liaison, NSERC Program
Jennifer Protudjer, MSc., Manitoba Institute of Child Health
Dr. Diana Royce, Managing Director and COO, AllerGen NCE Inc.
Updated March 2011